Amarin | AMRN - Pasivo Circulante

Precio De Mercado
14.75
Cambio Diario
0.06 0.37%
Mensual
1.13%
Anual
60.87%
Q2 Expectativa
14.28




Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amarin USD 194.46M 12.23M 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
DBV Technologies USD 49.48M 60K 2025-09
Esperion Therapeutics USD 300.81M 58.22M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12